Best Supportive Care or Chemotherapy for Stage IV Non-Small Cell Lung Cancer

This publication has 24 references indexed in Scilit:

• 26 Mitomycin, ifosfamide and cisplatin (MIC) in non-small cell lung cancer (NSCLC): 3. Results of a randomised trial evaluating palliation & quality of life
  Lung Cancer, 1997
• 24 Phase III study of gemcitabine (Gemzar®) versus best supportive care (BSC) in advanced non-small cell lung cancer (NSCLC)
  Lung Cancer, 1997
• Polychemotherapy in advanced non small cell lung cancer: a meta-analysis
  The Lancet, 1993
• Cisplatin-Cyclophosphamide-Mitomycin Combination Chemotherapy With Supportive Care Versus Supportive Care Alone for Treatment of Metastatic Non-Small-Cell Lung Cancer
  JNCI Journal of the National Cancer Institute, 1993
• Combined Chemotherapy and Radiotherapy versus Best Supportive Care in the Treatment of Inoperable Non-Small-Cell Lung Cancer
  Oncology, 1992
• Further evidence in favour of chemotherapy for inoperable non-small cell lung cancer
  Lung Cancer, 1990
• Non small cell lung cancer (NSCLC). A prospective randomized trial with alternating chemotherapy CEP/MEC' versus no treatment
  European Journal of Cancer and Clinical Oncology, 1988
• Beta blockade during and after myocardial infarction: An overview of the randomized trials
  Progress in Cardiovascular Diseases, 1985
• Benefits of polychemotherapy in advanced non-small-cell bronchogenic carcinoma
  Cancer, 1982
• A method for assessing the quality of a randomized control trial
  Controlled Clinical Trials, 1981